Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”
Year: 2025
Type: editorial
Abstract: Psychiatry stands at a turning point, where molecular insights promise to revolutionize how we diagnose, monitor, and treat neuropsychiatric conditions, including Alzheimer's, Parkinson's, depression, dementia, and schizophrenia (SCZ), among others [...].
Author: Masaru Tanaka
Institutions: University of Szeged, Hungarian Research Network
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W4415401768
